Biologic therapy practices in severe asthma; outcomes from the <scp>UK</scp> Severe Asthma Registry and survey of specialist opinion-Reference-Cited by-同舟云学术

Biologic therapy practices in severe asthma; outcomes from the UK Severe Asthma Registry and survey of specialist opinion

Published:2022-09-17 Issue:2 Volume:53 Page:173-185
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Experimental Allergy

Author:

Mansur Adel H.¹^ORCID,Gonem Sherif²,Brown Thomas³,Burhan Hassan⁴,Chaudhuri Rekha⁵,Dodd James W.⁶,Pantin Thomas⁷,Gore Robin⁸,Jackson David⁹¹⁰,Menzies‐Gow Andrew¹¹,Patel Mitesh¹²,Pavord Ian¹³,Pfeffer Paul¹⁴¹⁵,Siddiqui Salman¹⁶¹⁷,Busby John¹⁸,Heaney Liam G.¹⁹,Doherty Martin,Masoli Matthew,Message Simon,Stone Robert,Subramanian Deepak,

Affiliation:

1. Birmingham Regional Severe Asthma Service, Heartlands Hospital University Hospitals Birmingham and University of Birmingham Birmingham UK

2. Department of Respiratory Medicine Nottingham University Hospitals NHS Trust Nottingham UK

3. Portsmouth Hospitals University NHS Trust Portsmouth UK

4. Liverpool University Hospitals NHS Foundation Trust and University of Liverpool Liverpool UK

5. Gartnavel General Hospital Glasgow and University of Glasgow Glasgow UK

6. North Bristol Complex Airways Service, Southmead Hospital, North Bristol NHS Trust & Academic Respiratory Unit, Translational Health Sciences, Bristol Medical School University of Britsol Britsol UK

7. Severe Asthma Service, Wythenshawe Hospital Manchester University NHS Foundation Trust Manchester UK

8. Cambridge University Hospitals NHS Foundation Trust Cambridge UK

9. Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust London UK

10. School of Immunology & Microbial Sciences King's College London London UK

11. Royal Brompton and Harefield Hospitals London UK

12. Derriford Hospital University Hospitals Plymouth NHS Trust Plymouth UK

13. Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, Infection and Inflammation University of Oxford Oxford UK

14. Department of Respiratory Medicine Barts Health NHS Trust London UK

15. Barts and the London School of Medicine and Dentistry Queen Mary University of London London UK

16. Department of Respiratory Medicine, College of Life Sciences University of Leicester Leicester UK

17. Leicester NIHR Biomedical Research Centre (Respiratory Theme) Glenfield Hospital Leicester UK

18. Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences Queens University Belfast Belfast UK

19. Wellcome‐Wolfson Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences Queen's University Belfast Belfast UK

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.14222

Reference32 articles.

1. The Global Asthma Report2018. Accessed July 11 2021.http://globalasthmareport.org/

2. The prevalence of severe refractory asthma

3. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry

4. The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis

5. A review of respiratory biologic agents in severe asthma;Johnson N;Cureus,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort;Allergy;2024-06-22

2. Direct comparative study of anti-IgE and anti-IL4Rα therapy effectiveness in patients with severe allergic and mixed bronchial asthma;Meditsinskiy sovet = Medical Council;2024-06-06

3. Clinical and allergological characteristics of patients with severe bronchial asthma in the regional registry and phenotyping principles for the targeted therapy choice;Meditsinskiy sovet = Medical Council;2024-06-06

4. Severe asthma care trajectories: the French RAMSES cohort;ERJ Open Research;2024-02-29

5. Real-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSAR;Allergy, Asthma & Immunology Research;2024